BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced full enrollment ...

We are living in an epidemic of chronic disease, with a growing number of pesticides, chemicals and food additives implicated in the declining health of Americans. Since 2019, another factor has been ...

BioVie CEO Cuong Do joined Steve Darling from Proactive to announce the successful completion of patient enrollment for the company’s ADDRESS-LC Phase 2 clinical study evaluating its drug candidate ...

A Mount Sinai-led research team has demonstrated that autoimmunity, in which the body's immune system attacks its own tissues ...

Five years since the pandemic began, millions of people are still grappling with long covid, even as new patients are joining their ranks. “Considering how far along we are and how tens of millions of ...

Erica Hayes, 40, hasn't felt healthy since November 2020 when she first fell ill with COVID. Hayes is too sick to work, so she's spent much of the last four years sitting on her beige couch, often ...

Moore Vogel is a long Covid patient-researcher at Scripps Research and the Patient Led Research Collaborative (PLRC). Charlie McCone is a long Covid patient advocate, is a member of the PLRC, and has ...

Researchers are launching a new study to investigate whether GLP-1 drugs, already approved for type 2 diabetes and obesity, could help treat long COVID symptoms. The medications are currently being ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Amidst a resurgence of COVID-19 cases across the United States, ...

Erica Hayes, 40, has not felt healthy since November 2020 when she first fell ill with COVID. Hayes is too sick to work, so she has spent much of the last four years sitting on her beige couch, often ...